ES2181257T3 - Sistema terapeutico transdermico (stt) para la administracion de hormonas esteroideas sexuales. - Google Patents

Sistema terapeutico transdermico (stt) para la administracion de hormonas esteroideas sexuales.

Info

Publication number
ES2181257T3
ES2181257T3 ES98939550T ES98939550T ES2181257T3 ES 2181257 T3 ES2181257 T3 ES 2181257T3 ES 98939550 T ES98939550 T ES 98939550T ES 98939550 T ES98939550 T ES 98939550T ES 2181257 T3 ES2181257 T3 ES 2181257T3
Authority
ES
Spain
Prior art keywords
sexual
hormones
therapeutic system
transdermal therapeutic
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98939550T
Other languages
English (en)
Inventor
Hans-Michael Wolff
Christoph Arth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanol Schwarz GmbH
UCB Pharma GmbH
Original Assignee
Sanol Schwarz GmbH
Schwarz Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Schwarz GmbH, Schwarz Pharma AG filed Critical Sanol Schwarz GmbH
Application granted granted Critical
Publication of ES2181257T3 publication Critical patent/ES2181257T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Sistema terapéutico transdérmico (STT) para la administración transcutánea de esteroides sexuales durante largos espacios de tiempo con una ayuda de fijación para el STT sobre la piel, caracterizado porque el STT contiene una masa matriz en forma de capa que contiene hormonas esteroideas, la cual contiene copolímeros de (met)acrilato que contienen grupos amonio y al menos un plastificante, en solitario o en mezcla con un terpolímero de etilenacrilato, al menos 2 por ciento en peso de cada hormona esteroidea distribuida en dispersión molecular en la masa matriz y ésta, con excepción de su superficie para liberación sobre la piel, está rodeada por un emplasto más grande, exento de sustancia activa, para la fijación en el sitio de aplicación.
ES98939550T 1997-07-04 1998-06-29 Sistema terapeutico transdermico (stt) para la administracion de hormonas esteroideas sexuales. Expired - Lifetime ES2181257T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19728517A DE19728517C2 (de) 1997-07-04 1997-07-04 TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ES2181257T3 true ES2181257T3 (es) 2003-02-16

Family

ID=7834591

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98939550T Expired - Lifetime ES2181257T3 (es) 1997-07-04 1998-06-29 Sistema terapeutico transdermico (stt) para la administracion de hormonas esteroideas sexuales.

Country Status (18)

Country Link
US (1) US6562367B1 (es)
EP (1) EP1003490B1 (es)
JP (1) JP2002508778A (es)
KR (1) KR100370647B1 (es)
CN (1) CN1195501C (es)
AT (1) ATE223710T1 (es)
AU (1) AU749474B2 (es)
BR (1) BR9815512A (es)
CA (1) CA2295720A1 (es)
DE (2) DE19728517C2 (es)
DK (1) DK1003490T3 (es)
ES (1) ES2181257T3 (es)
HK (1) HK1031693A1 (es)
IL (1) IL133659A (es)
NZ (1) NZ502352A (es)
PT (1) PT1003490E (es)
WO (1) WO1999001116A1 (es)
ZA (1) ZA985864B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821788C1 (de) * 1998-05-15 1999-12-02 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Pergolid enthaltend
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19828274C2 (de) * 1998-06-25 2002-11-28 Rottapharm Bv Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
AU3478200A (en) * 1999-02-02 2000-08-25 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10033855A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
US20060067995A1 (en) * 2004-07-02 2006-03-30 Heng Wan Sia P Topical and/or transdermal bioactive compound delivery system
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
TWI741168B (zh) * 2017-04-28 2021-10-01 日商日東電工股份有限公司 經皮吸收製劑
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6139868A (en) * 1986-08-28 2000-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
SK130298A3 (en) * 1996-03-25 1999-03-12 Lohmann Therapie Syst Lts Transdermal therapeutic system with small application-area thickness and great flexibility, and production process
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems

Also Published As

Publication number Publication date
EP1003490B1 (de) 2002-09-11
CN1269716A (zh) 2000-10-11
DE19728517C2 (de) 1999-11-11
NZ502352A (en) 2001-08-31
AU8802198A (en) 1999-01-25
EP1003490A1 (de) 2000-05-31
BR9815512A (pt) 2001-11-27
JP2002508778A (ja) 2002-03-19
KR100370647B1 (ko) 2003-02-05
DE59805536D1 (de) 2002-10-17
IL133659A0 (en) 2001-04-30
HK1031693A1 (en) 2001-06-22
CN1195501C (zh) 2005-04-06
KR20010021493A (ko) 2001-03-15
ATE223710T1 (de) 2002-09-15
AU749474B2 (en) 2002-06-27
IL133659A (en) 2004-07-25
DE19728517A1 (de) 1999-01-07
CA2295720A1 (en) 1999-01-14
WO1999001116A1 (de) 1999-01-14
PT1003490E (pt) 2003-01-31
US6562367B1 (en) 2003-05-13
DK1003490T3 (da) 2002-10-14
ZA985864B (en) 1998-10-23

Similar Documents

Publication Publication Date Title
ES2181257T3 (es) Sistema terapeutico transdermico (stt) para la administracion de hormonas esteroideas sexuales.
NO980277L (no) Hormonplaster
BRPI0113670B8 (pt) composição farmacêutica e método para tratar hipogonadismo
ES2123500T3 (es) Derivados de 8-heterociclil-2-aminotetralina activos sobre el sistema nervioso central.
DK41988D0 (da) Doseringsenhed til transdermal absorption af estradiol og andre estrogene steroider, samt fremgangsmaade til administrering af disse
DK0971705T3 (da) Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden
UA29476C2 (uk) Трансдермальна терапевтична система, що містить естрадіол
FI875229A0 (fi) Menetelmä uusien farmakologisesti aktiivisten katekolijohdoksien valmistamiseksi
ZA985863B (en) Transdermal therapeutic system
NO993385L (no) Transdermalt terapeutisk system for avgivelse av hormoner
DK1383540T3 (da) Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
ATE205401T1 (de) Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8
ES2165232T3 (es) Sistema terapeutico transdermico (tts) que contiene oxibutinina.
DK0825865T3 (da) Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
WO1999027990A3 (en) Stereospecific delivery of a drug using electrotransport
NO20000814L (no) Identifikasjon for klebende flateformede dermale og transdermale terapeutiske administrasjonsformer under anvendelse av et klebende plaster som informasjonsbærer, såvel som fremgangsmåte for deres fremstilling
HUP9903340A2 (hu) Trimegeszton transzdermális adagolására szolgáló új eszköz, és eljárás előállítására
ZA973749B (en) Transdermal administration of steroid hormones using diethanolamides of C12-C18 fatty acids as permeation enhancers.
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider
ATE252895T1 (de) Transdermales therapeutisches system und verfahren zu seiner herstellung
PT866798E (pt) Preparacao de derivados esterificados de esteroides
DE69909097D1 (de) 5-bicycloindolverbindungen
UA28489A (uk) Спосіб лікування затримки статевого розвитку у хлопцівпідлітків
UA23971A (uk) Спосіб комплексhого лікуваhhя хворих деструктивhим туберкульозом легеhь